Covalent Ventures is an active health & wellness sector investor based in Aotearoa New Zealand. We work with companies in the ecosystem to scale into global brands, creating real-world impact in major markets.
Global Impact Through Responsible Investments
Covalent Ventures is a globally connected health & wellness impact investor, leveraging the team’s deep global healthcare sector experience with coverage across biotech/ pharma, medical devices, digital health, mental health, healthcare systems, novel ingredients, consumer packaged goods and other allied sectors.
We assist growth stage companies to scale and compete in major global markets and provide portfolio companies with an immediate unfair advantage by leveraging our deep sector knowledge and extensive global networks.
Kelvin has served on the boards of a number of companies and is a current board member of the EpiGen Global Research Consortium with headquarters in UK and was previously on the Boards of Energia Portior Limited, UniServices (Hong Kong) Limited, and Chair of Foundation Ventures. He has formal qualifications in Biotechnology and Chemical Engineering from the University of Auckland and is a Chartered Member of the Institute of Directors.
Chris is also an experienced consultant assisting several small biotech companies with business plans and commercial propositions. Previously Chris was CEO & Founding Partner of GfK Research Matters AG, a global healthcare market research and marketing consultancy in Basel, which, was later acquired by GfK Global Healthcare.
Chris is a very active member in the not-for-profit sector in Basel, playing a key role in fundraising for the Cancer Society ‘Krebsliga beider Basel’, Schweizer Tafel (poverty alleviation), and previously for the Renner Stiftung (support to relatives and carers of cancer sufferers). She is also a member of the Rotary Club Basel.